Cognitive Function with the Mediterranean Diet in Multiple Sclerosis
The following is a summary of “Mediterranean Diet is Associated with Cognition in Multiple...
Read MoreApr 14, 2023
The following is a summary of “Mediterranean Diet is Associated with Cognition in Multiple...
Read MoreApr 14, 2023
The following is a summary of “Association of Specific “Critical” Demyelinating Lesions and...
Read MoreApr 14, 2023
The following is a summary of “Vigilance Improves in People with Multiple Sclerosis (MS) and Fatigue following Repeated Dorsolateral Prefrontal Cortex Transcranial Direct Current Stimulation (tDCS) Sessions Paired with...
Read MoreApr 14, 2023
The following is a summary of “Influence of Cardiorespiratory Fitness and MRI Measures of...
Read MoreApr 14, 2023
The following is a summary of “Identifying Multiple Sclerosis Relapses from Clinical Notes...
Read MoreApr 10, 2023
All sessions held in the Convention Center will be live-streamed to the virtual meeting platform....
Read MoreApr 10, 2023
Date/Time: Saturday, April 15, 2023; 7:30-10:30 a.m. ET Start/Finish: Orange County Convention...
Read MoreApr 10, 2023
FRIDAY, APRIL 14 12:00 p.m. Registration Opens 3:00 p.m.-4:30 p.m. Educational Sessions and...
Read MoreApr 10, 2023
The following is a summary of “Comparison of risk factors to molecular risk stratification...
Read MoreApr 7, 2023
The following is a summary of “Clinical outcomes and molecular features of different histopathologic patterns in patients with stage IB non-squamous non-small-cell lung cancer,” published in the April 2023 issue of...
Read MoreApr 7, 2023
The following is a summary of “Hierarchy of prognostic quality markers after curative-intent...
Read MoreApr 7, 2023
The following is a summary of “Comparative characteristics of stage I non-small cell lung...
Read MoreApr 7, 2023
The following is a summary of “Tumor-informed fixed and patient-specific panels for minimal...
Read MoreMar 23, 2023
All our ASCO GI 2023 features in one convenient place! ASCO GI Cancer 2023.indd
Read MoreMar 23, 2023
For people who are HIV-positive (PWH), initiating ART with integrase strand transfer inhibitor...
Read MoreMar 10, 2023
Among people with HIV (PWH), racial disparities in cancer outcomes have not been fully examined in...
Read MoreMar 8, 2023
People with HIV experience a high prevalence of mental health (MH) conditions and associated...
Read MoreFeb 22, 2023
The following is a summary of “DOUBLING DOLUTEGRAVIR DOSAGE REDUCES HIV PERSISTENCE MARKERS...
Read MoreFeb 22, 2023
The following is a summary of “D2EFT: DOLUTEGRAVIR AND DARUNAVIR EVALUATION IN ADULTS...
Read More